As Bay­er, No­var­tis stack up their ra­dio­phar­ma­ceu­ti­cal da­ta at #ES­MO21, a key de­bate takes shape

Ten years ago, a small Nor­we­gian biotech by the name of Al­ge­ta showed up at ES­MO — then the Eu­ro­pean Mul­ti­dis­ci­pli­nary Can­cer Con­fer­ence 2011 — and de­clared …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER